≡

Multiplex Assay Kit for Lectin Galactoside Binding, Soluble 3 Binding Protein (LGALS3BP) ,etc. by FLIA (Flow Luminescence Immunoassay)

MAC-2-BP; LGALS3-BP; Galectin-3-Binding Protein; L3 Antigen; Mac-2-Binding Protein; Tumor-associated antigen 90K; Serum Protein 90K; Basement membrane autoantigen p105

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of Lectin Galactoside Binding, Soluble 3 Binding Protein (LGALS3BP) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Lectin Galactoside Binding, Soluble 3 Binding Protein (LGALS3BP) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Lectin Galactoside Binding, Soluble 3 Binding Protein (LGALS3BP) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Lectin Galactoside Binding, Soluble 3 Binding Protein (LGALS3BP) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 93-101 97
EDTA plasma(n=5) 79-104 88
heparin plasma(n=5) 93-101 98
sodium citrate plasma(n=5) 81-93 85

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Lectin Galactoside Binding, Soluble 3 Binding Protein (LGALS3BP) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Lectin Galactoside Binding, Soluble 3 Binding Protein (LGALS3BP) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Lectin Galactoside Binding, Soluble 3 Binding Protein (LGALS3BP) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 93-101% 88-95% 88-96% 90-102%
EDTA plasma(n=5) 91-102% 98-105% 80-90% 80-101%
heparin plasma(n=5) 88-97% 97-105% 95-103% 80-101%
sodium citrate plasma(n=5) 97-105% 87-101% 78-93% 86-93%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:LGALS3BP) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Andrology Comparative proteomic analysis coupled with conventional protein assay as a strategy to identify predictors of successful testicular sperm extraction in patients with non-obstructive azoospermia PubMed: 23427166
Liver International Identification of candidate biomarkers for hepatocellular carcinoma in plasma of HCV-infected cirrhotic patients by 4-D DIGE Pubmed: 23944848
Acta Anaesthesiologica Scandinavica Early prognostic factors in septic shock cancer patients: a prospective study with a proteomic approach Pubmed:29315472
Catalog No. Related products for research use of Mus musculus (Mouse) Organism species Applications (RESEARCH USE ONLY!)
RPB766Mu02 Recombinant Lectin Galactoside Binding, Soluble 3 Binding Protein (LGALS3BP) Positive Control; Immunogen; SDS-PAGE; WB.
RPB766Mu01 Recombinant Lectin Galactoside Binding, Soluble 3 Binding Protein (LGALS3BP) Positive Control; Immunogen; SDS-PAGE; WB.
PAB766Mu01 Polyclonal Antibody to Lectin Galactoside Binding, Soluble 3 Binding Protein (LGALS3BP) WB; IHC; ICC; IP.
PAB766Mu02 Polyclonal Antibody to Lectin Galactoside Binding, Soluble 3 Binding Protein (LGALS3BP) WB; IHC; ICC; IP.
SEB766Mu ELISA Kit for Lectin Galactoside Binding, Soluble 3 Binding Protein (LGALS3BP) Enzyme-linked immunosorbent assay for Antigen Detection.
LMB766Mu Multiplex Assay Kit for Lectin Galactoside Binding, Soluble 3 Binding Protein (LGALS3BP) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.